Canary Islands Invests 12 Million to Improve Diagnostic Imaging in Tenerife

The Canary Health Service and the Cabildo of Tenerife join forces to expand magnetic resonance and ultrasound capabilities, reducing waiting lists.

Generic image of medical diagnostic imaging equipment.
IA

Generic image of medical diagnostic imaging equipment.

The Canary Health Service (SCS) and the Cabildo of Tenerife have formalized two contracts with the public company IMETISA totaling 12.1 million euros to enhance diagnostic capacity for magnetic resonance and ultrasound in the island, aiming to reduce waiting times.

The investment is divided into 9.8 million euros to increase diagnostic capacity for magnetic resonance and 2.3 million euros for ultrasound diagnostic services. These contracts, with an initial duration of four years and the possibility of extension, will allow for approximately 20,000 diagnostic imaging studies per year at IMETISA facilities, expanding coverage to patients from Tenerife's reference hospitals.
The director of the SCS, Adasat Goya, and the president of the Cabildo of Tenerife, Rosa Dávila, presented the agreement. They highlighted that IMETISA will act as a public service provider to absorb the volume of tests and improve the public health system's response. Goya thanked the Cabildo for its collaboration and praised IMETISA's experience, while Dávila emphasized the commitment to utilize the island's resources to reduce waiting times.
The director of the Tenerife Health Area, Diana Mora, detailed that the MRI contract will extend coverage to patients from Tenerife's two public hospitals and those from non-capital islands referred to these centers. Regarding ultrasounds, a new high-end ultrasound machine will enable around 9,000 annual studies, strengthening diagnostic capabilities.
The Minister of Innovation of the Cabildo of Tenerife, Juan José Martínez, underscored IMETISA's role as a specialized public instrument and the importance of healthcare technology in improving people's lives, ensuring a safe and quality care process.
Specifically, the allocation for magnetic resonance (9,818,480 euros) will be distributed between 2026 and 2030, anticipating approximately 11,000 annual studies. IMETISA, located near the HUC, already provides MRI services and will now extend its assistance to patients from Tenerife's two main public hospitals, as well as those referred from other islands.
For ultrasound services, 2,364,800 euros are allocated, also between 2026 and 2030, for around 9,000 annual diagnostic studies using a state-of-the-art ultrasound machine. Services will be provided at IMETISA facilities, with the possibility of extending to other SCS locations based on demand.
Based on information from the official source: Gobierno de Canarias — Portal de Noticias (08/09/2026)